Bionika Pharmaceuticals is a pharmaceutical company specializing in the production of solid, semisolid, and liquid dosage forms. Founded in 2010, the company is dedicated to serving the regional market while adhering to the highest standards set by the global pharmaceutical industry. Its manufacturing processes, quality control laboratory, microbiology laboratory, and R&D laboratory align with the latest requirements of Good Manufacturing Practice (GMP) and Good Quality Control Laboratory Practices, ensuring compliance with production and quality standards. Moreover, the warehouse meets the requirements of Good Storage Practice, with an installed SCADA system that regulates air temperature and humidity to maintain optimal storage conditions for products.
The core values of Bionika Pharmaceuticals revolve around a commitment to high quality, a proactive approach to adopting pharmaceutical industry innovations, fostering strong relationships with consumers and clients, flexibility and adaptability to customer needs, fair treatment of markets, and a focus on environmental and social responsibility.
The company operates within the Manufacturing, Pharmaceutical, and Marketing industries, positioning itself at the intersection of these sectors. It presents a compelling opportunity for venture capitalists seeking exposure to the pharmaceutical manufacturing space and a commitment to upholding global industry standards.